Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PolyGene

PolyGene?uq=hBqTzBbB
2002 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a research institute intended to enhance transgenic research endeavors. The company's research institute offers state-of-the-art transgenic animal model with focus on gene regulation, cell culture and genotyping, enabling scientists to attain comprehensive growth in cell research and development.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Primary Office
  • Riedmattstrasse 9
  • 8153 Rümlang
  • Switzerland

+41 044 000 00 00

PolyGene Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore PolyGene‘s full profile, request access.

Request full access to PitchBook

PolyGene Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore PolyGene‘s full profile, request access.

Request full access to PitchBook

PolyGene Executive Team (1)

Name Title Board
Seat
Contact
Info
Doron Shmerling Co-Founder & Chief Executive Officer